Posted on 1/22/21
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) is a blue-chip pharma stock with annual revenues in the neighborhood of $80 billion -- and that's before considering the potential of . . .
Posted on 1/22/21
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
The distribution of coronavirus vaccines in lower-income countries could get a huge boost soon. On Thursday, two sources familiar with the matter told Reuters that Pfizer . . .
Posted on 1/22/21
Caladrius Biosciences Announces $25M Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/21/21
OncoSec Medical Prices of $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
Caladrius Biosciences Announces $25.0 Million Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/21/21
CorMedix to Begin Trading on the Nasdaq Stock Exchange
BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 1/21/21
Inovio Pharma Secures $150.5M Capital Raise
Inovio Pharmaceuticals (NASDAQ:INO) has priced its public offering of 17.7M common shares at $8.50/share, for expected gross proceeds of ~$150.5M.Underwriters' over-allotment is an additional ~2.7M shares.Net . . .
Posted on 1/21/21
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
Vaccine partners Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) released information today that provides new evidence that their COVID-19 vaccine is effective against the B.1.1.7 variant that was . . .
Posted on 1/21/21
Aclaris Prices Public Offering of Common Stock
WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today . . .
Posted on 1/21/21
INOVIO Proposes Public Offering of Common Stock
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including . . .
Posted on 1/21/21
OncoSec Medical Proposes Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
INOVIO Prices Public Offering of Common Stock
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including . . .
Posted on 1/20/21
Aclaris Prices of Public Offering of Common Stock
WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today . . .
Posted on 1/20/21
Where Will Pfizer Be in 5 Years?
Investors threw piles of money at up-and-coming biotechs last year, and that was before the coronavirus pandemic accelerated the trend even further. This capital isn't taking . . .
Posted on 1/20/21
Passage Bio Announces Launch of Proposed Public Offering
PHILADELPHIA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare monogenic central nervous . . .
Posted on 1/20/21
Aclaris Announces Proposed Public Offering of Common Stock
WAYNE, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, . . .
Posted on 1/19/21
Ortho Clinical Diagnostics Launch of IPO
Ortho Clinical Diagnostics Holdings plc, the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, . . .
Posted on 1/19/21
Helius Medical Technologies Regains Compliance with Nasdaq Listing Standards
NEWTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), a neurotech company focused on neurological wellness, today announced that it received . . .
Posted on 1/19/21
Can the Pfizer and Moderna Vaccines Beat the New Coronavirus Strains?
Investors in Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) may have breathed a sigh of relief when the U.S. Food and Drug Administration granted the companies' coronavirus vaccines . . .
Posted on 1/19/21
Is Pfizer Stock a Buy?
Let me get cut to the chase: Yes, I think Pfizer (NYSE:PFE) stock is a buy. And yes, I realize that could be surprising considering that . . .
Posted on 1/19/21
Should You Buy Johnson & Johnson For Its COVID Vaccine?
So far, some coronavirus vaccine stocks have offered investors enormous gains in a short period of time. For example, Moderna (NASDAQ:MRNA) stock climbed more than 400% . . .
Posted on 1/15/21
Gamma Biosciences to Acquire BioMagnetic Solutions
Gamma Biosciences, a life sciences tool platform created by KKR, has agreed to acquire State College, Pennsylvania based, BioMagnetic Solutions (BMS), a next-generation cell selection and . . .
Posted on 1/15/21
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Genetic testing expert Invitae (NYSE:NVTA) has received the backing of some of the largest pharmaceutical companies in the industry. Bristol Myers Squibb (NYSE:BMY), Johnson & Johnson . . .
Posted on 1/14/21
KidsX Selects 13 Startups for Inaugural Cohort
LOS ANGELES--(BUSINESS WIRE)--KidsX, an international consortium of pediatric hospitals focused on improving digital health innovation through collaboration, has selected 13 startup companies to be part of . . .
Posted on 1/14/21
TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020
MALVERN, Pa., Jan. 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category . . .
Philadelphia
